Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi-centre and Multi-modal Approach

Abroad (travel likely)RecruitingPHASE3

Conditions

Parkinson's Disease (PD) · Freezing of Gait · Freezing of Gait Symptoms in Parkinson Disease

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Radboudumc, Nijmegen, Gelderland, Netherlands
Contact: Study coordinator (Franka Goossens) · franka.goossens@radboudumc.nl · +31243668426

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease

Parkinson Disease · Parkinson · Idiopathic Parkinson Disease

IsraelRecruitingPHASE2

Sun City, United States · Little Rock, United States

Use of CereGate Therapy for Freezing of Gait in PD

Parkinson Disease · Freezing of Gait · Deep Brain Stimulation

Abroad (travel likely)Recruiting

Redwood City, United States · Aurora, United States

Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's Disease

Parkinson Disease

Abroad (travel likely)RecruitingPHASE2

Farmington Hills, United States

Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease

Healthy Volunteers (HV) · Parkinson's Disease (PD)

Abroad (travel likely)RecruitingPHASE1

Leiden, Netherlands